June 10, 2013 – The Association of Medical Microbiology and Infectious Disease Canada (AMMI Canada) has developed a document to help guide front-line clinicians on the use of antiviral drugs for avian influenza A(H7N9) virus in the event that cases of the novel virus emerge in Canada. Interim Guidance for Antiviral Prophylaxis and Treatment of Influenza Illness due to Avian Influenza A(H7N9) Virus provides required information on the use of antivirals for the prevention and clinical management of influenza-like illness due to infection by avian influenza A(H7N9) virus.